Mappa tal-evidenza
Allerġija barra: x'jidhru l-evidenzi
12 pubblikazzjonijiet, 3 minnhom trials u 5 sintesi. Din il-paġna tiddeskrivi l-forma ta' dik il-letteratura minflok tissummara l-konklużjonijiet tagħha.
X'jikkostitwixxi din il-letteratura
Is-sintesi hija 'l quddiem mill-letteratura primarja hawn — reviżjonijiet u meta-analiżi li jdraw fuq numru modest ta' studji bażiċi. Ittieħed konklużjonijiet b'fiduċja bil-kawtela li l-għadd tal-kampjonu jixraqlu.
L-iskop li jimporta l-aktar huwa bejn is-sintesi u r-riċerka primarja. Meta-analiżi tikkonsolida t-trials u hija l-aktar ħaġa viċin ta' tweġiba stabbilita li l-qasam jipproduċi. Reviżjoni narrattiva hija qari ta' grupp wieħed tal-istess materjal u tista' tkun selettiva mingħajr ma tkun diżonesta. L-għadd tagħhom flimkien, li ħafna mill-għadd ta' ċitazzjonijiet jagħmlu, jiskopri eżattament il-ħaġa li trid tkun taf.
Kif hi mibnija din il-paġna
Kollox hawn fuq huwa kkalkulat mill-ċitazzjonijiet li dan is-sit ħa minn PubMed u Crossref, mhux miktub bil-hand. Meta l-ħsad settimanali jsib paper ġdid dwar dan is-suġġett, dawn il-għaddijiet jinbidlu u l-karatterizzazzjoni tinbidel magħhom. Dak huwa l-punt: dikjarazzjoni miktuba bil-hand dwar kemm hija b'saħħitha l-bażi ta' evidenza tibda tiżdied il-ġurnata li tkun miktuba.
It-tip ta' pubblikazzjoni huwa meħud kif ir-rekords tas-sors jindika. Dan mhuwiex perfett — il-ġurnali jlabeljaw b'mod inkonsistenti, u paper indikata bħala "reviżjoni" tista' tkun waħda sistematika — għalhekk it-trattament tal-bandi bħala approssimattivi. Huma biżżejjed preċiżi biex jiddistingwu letteratura ta' trial minn letteratura ta' kumment, li huwa l-iskop li jimporta.
L-aktar xogħol b'saħħtu dwar dan is-suġġett
Ordnat skont id-disinn tal-istudju l-ewwel, imbagħad ir-riċentezza. Is-sett sħiħ huwa elenkat fir-referenzi hawn taħt.
- Ir-riskju ta' anafilassi fuq titjiriet kummerċjali — Turner PJ, 2025, reviżjoni sistematika
- Kemm huma Komuni r-Reazzjonijiet Allerġiċi Matul it-Titjiriet Kummerċjali? Reviżjoni Sistemika u Meta-Analiżi — Turner PJ, Mamula J, Laktabi J et al., 2023, meta-analiżi
- Interventi ta' kura tal-ġilda f'infant għal prevenzjoni ta' eczema u allerġija għall-ikel — Kelleher MM, Cro S, Cornelius V et al., 2021, meta-analiżi
- Frekwenza, severità u kawżi ta' reazzjonijiet allerġiċi inaspettati għall-ikel: reviżjoni sistematika tal-letteratura — Versluis A, Knulst AC, Kruizinga AG et al., 2015, reviżjoni sistematika
- Linji gwida tal-EAACI għall-allerġija għall-ikel u anafilassi: immaniġġjar tal-pazjenti b'allerġija għall-ikel fil-komunità — Muraro A, Agache I, Clark A et al., 2014, linja gwida klinika
- L-effetti ta' supplimentazzjoni ta' prebiotiċi matul it-tqala u l-allattament fuq mard allerġiku fl-infant: trial kontrollat randomizzat — Palmer DJ, Cuthbert AR, Sullivan TR et al., 2025, trial kontrollat randomizzat
- Dieta ta' eliminazzjoni ta' ikel wieħed kontra dieta ta' eliminazzjoni ta' ikel sitt għall-kura ta' eosinophilic oesophagitis: trial multikentriku, randomizzat, miftuħ00012-2) — Kliewer KL, Gonsalves N, Dellon ES et al., 2023, trial kontrollat randomizzat
- Mepolizumab għal tfal urbani b'asma eosinophilic prone għall-esacerbazzjoni fl-USA (MUPPITS-2): trial randomizzat, doppju-blind, kontrollat bil-placebo, grupp parallelo01198-9) — Jackson DJ, Bacharier LB, Gergen PJ et al., 2022, trial kontrollat randomizzat
- Test ta' Attivazzjoni tal-Basophil: Bridging Allergy and Oncology for Diagnostic, Therapeutic and Prognostic Applications in AllergoOncology: An EAACI Position Paper — Pascal M, Chauhan J, Knol E et al., 2025, reviżjoni
- Il-teorija tal-barriera epiteljali u l-mard assoċjati magħha — Sun N, Ogulur I, Mitamura Y et al., 2024, reviżjoni
Kemm hemm riċerka dwar allerġija barra?
Iżda riċerka aktar ħafna tfisser konklużjoni iktar b'saħħitha?
Kemm hi attwali din?
Għaliex din il-paġna ma tgħidx lili l-għażla?
Referenzi
Kull ċitazzjoni hawn taħt tgħaqqad mal-record oriġinali peer-reviewed fuq PubMed jew permezz ta' DOI. Xejn hawnhekk m'għandux ikun sostitut għal parir mediku.
-
Risk of anaphylaxis on commercial flights Turner PJ · Current opinion in allergy and clinical immunology · 2025 · Systematic review DOIPubMed 40643054Full text
-
How Common Are Allergic Reactions During Commercial Flights? A Systematic Review and Meta-Analysis Turner PJ, Mamula J, Laktabi J, et al. · The journal of allergy and clinical immunology. In practice · 2023 · Meta-analysis DOIPubMed 37507067
-
Skin care interventions in infants for preventing eczema and food allergy Kelleher MM, Cro S, Cornelius V, et al. · The Cochrane database of systematic reviews · 2021 · Meta-analysis DOIPubMed 33545739Full text
-
Frequency, severity and causes of unexpected allergic reactions to food: a systematic literature review Versluis A, Knulst AC, Kruizinga AG, et al. · Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2015 · Systematic review DOIPubMed 24766413
-
EAACI food allergy and anaphylaxis guidelines: managing patients with food allergy in the community Muraro A, Agache I, Clark A, et al. · Allergy · 2014 · Clinical guideline DOIPubMed 24905609
-
Exploratory analyses of predictors and correlates of response to omalizumab therapy in patients with multiple food allergies Chinthrajah RS, Kulis M, Jones SM, et al. · The Journal of allergy and clinical immunology · 2026 · Randomised controlled trial DOIPubMed 41238005Full text
-
PrecISE-a biomarker-stratified adaptive trial of 5 interventions in severe asthma: Final protocol and the baseline cohort Denlinger LC, Israel E, Moore WC, et al. · The Journal of allergy and clinical immunology · 2026 · Randomised controlled trial DOIPubMed 41707916Full text
-
Early-life peanut oral immunotherapy associated with long-term ingestion and immunologic changes Dantzer JA, Virkud YV, Cox AL, et al. · The Journal of allergy and clinical immunology · 2026 · Randomised controlled trial DOIPubMed 42167657Full text
-
Effects of pregnancy and lactation prebiotics supplementation on infant allergic disease: A randomized controlled trial Palmer DJ, Cuthbert AR, Sullivan TR, et al. · The Journal of allergy and clinical immunology · 2025 · Randomised controlled trial DOIPubMed 39173718
-
A pediatric randomized, controlled trial of German cockroach subcutaneous immunotherapy Zoratti E, Wood R, Pomés A, et al. · The Journal of allergy and clinical immunology · 2024 · Randomised controlled trial DOIPubMed 38718950Full text
-
Double-Blind, Placebo-Controlled Study of E-B-FAHF-2 in Combination With Omalizumab-Facilitated Multiallergen Oral Immunotherapy Wang J, Wood RA, Raymond S, et al. · The journal of allergy and clinical immunology. In practice · 2023 · Randomised controlled trial DOIPubMed 37087097Full text
-
One-food versus six-food elimination diet therapy for the treatment of eosinophilic oesophagitis: a multicentre, randomised, open-label trial Kliewer KL, Gonsalves N, Dellon ES, et al. · The lancet. Gastroenterology & hepatology · 2023 · Randomised controlled trial DOIPubMed 36863390Full text
-
Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trial Jackson DJ, Bacharier LB, Gergen PJ, et al. · Lancet (London, England) · 2022 · Randomised controlled trial DOIPubMed 35964610Full text
-
Randomized, double-blind, placebo-controlled, food allergy challenge to olestra snacks Burks AW, Christie L, Althage KA, et al. · Regulatory toxicology and pharmacology : RTP · 2001 · Randomised controlled trial DOIPubMed 11603960
-
Basophil Activation Test: Bridging Allergy and Oncology for Diagnostic, Therapeutic and Prognostic Applications in AllergoOncology: An EAACI Position Paper Pascal M, Chauhan J, Knol E, et al. · Allergy · 2025 · Review DOIPubMed 40503572Full text
-
The epithelial barrier theory and its associated diseases Sun N, Ogulur I, Mitamura Y, et al. · Allergy · 2024 · Review DOIPubMed 39370939Full text
-
The restaurant syndromes Settipane GA · New England and regional allergy proceedings · 1987 · Review DOIPubMed 3302666
-
Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study Ozonoff A, Jayavelu ND, Liu S, et al. · Nature communications · 2024 · Journal article DOIPubMed 38172101Full text
-
Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019 Shin YH, Hwang J, Kwon R, et al. · Allergy · 2023 · Journal article DOIPubMed 37431853Full text